| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000033850 |
| Receipt No. | R000038602 |
| Scientific Title | Assessment of hip function using gait analysis system in hip disorder patients |
| Date of disclosure of the study information | 2018/08/22 |
| Last modified on | 2021/05/10 (Ver. 2) |
| Basic information | ||
| Public title | Assessment of hip function using gait analysis system in hip disorder patients | |
| Acronym | Gait analysis system for assessment of hip function | |
| Scientific Title | Assessment of hip function using gait analysis system in hip disorder patients | |
| Scientific Title:Acronym | Gait analysis system for assessment of hip function | |
| Region |
|
|
| Condition | ||
| Condition | Hip disorders | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Use of gait analysis system for the assessment of hip function and gait appearance in hip disorder patients |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | For the assessment of hip function, range of motion and muscle strength in hip will be measured by motion analysis system, CT imaging, and Anybody system.
For the assessment of gait appearance, body sway and stability will be measured by gait analysis system. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Age over 18years old
2. Patients with Hip osteoarthritis, osteonecrosis, development dysplasia of hip, limbs tear, groin pain syndrome who undergoes CT scanning. 3. Patients who can be undergone gait analysis 4. Patients who agreed with our study |
|||
| Key exclusion criteria | 1. Patient who are not able to walk independently
2. Patient who are judged as inappropriate by doctor |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama City University | ||||||
| Division name | Department of Orthopaedic Surgery | ||||||
| Zip code | |||||||
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa | ||||||
| TEL | 0457872655 | ||||||
| hyonmin@hotmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama City University | ||||||
| Division name | Department of Orthopaedic Surgery | ||||||
| Zip code | |||||||
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa | ||||||
| TEL | 0457872655 | ||||||
| Homepage URL | |||||||
| hyonmin@hotmail.com | |||||||
| Sponsor | |
| Institute | Yokohama City University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Science and Technology Agency |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Nothing |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038602 |